Stock info DSM-Firmenich | Filter Basic-Info
Stock: DSM-Firmenich (NL Amsterdam 25), ISIN: NL0000009827
| Last Price | 94.38 | Max Price | 94.38 |
| Min Price | 81.84 | 1 Year return | -0.51 |
| Avg. Target | 84.50 | Expected Return | -10.47 % |
| Sector | Basic Materials | Subsector | Chemicals |
| Sell | 0 | Rating |
|
| Hold | 2 | Concensus |
 
|
| Buy | 4 | ||
| Annual report 2018 |
Loading...
Contact info:Street: 6401 JH HeerlenPostbox: P.O. Box 6500City: HeerlenCountry: NetherlandsPhone: 31 (0)45 578 28Website: www.dsm.com
Sector Review DSM-Firmenich
Loading...
| Année | Chiffre d'affaires | Total du secteur | Part de marché |
|---|---|---|---|
| 2019 | 0 | 647,530 | 0.00 % |
| 2020 | 0 | 586,506 | 0.00 % |
| 2021 | 11,444 | 764,397 | 1.50 % |
| 2022 | 8,390 | 900,685 | 0.93 % |
| 2023 | 10,627 | 783,698 | 1.36 % |
Advice DSM-Firmenich
News DSM-Firmenich
Analysts foresee more revenue DSM
Over the current book year the total revenue from the company in Heerlen will be 9.92 billion euros (consensus estimates). This is quite more than 2022's revenue of 8.39 billion euros. Historical revenues and results DSM plus estimates 2023 The analysts...
Analysts expect over 2020 decreasing revenue DSM
Tomorrow the Dutch company DSM will publish its past quarters results. Over the current book year the total revenue from the company in Heerlen will be 8.44 billion euros (consensus estimates). This is slightly lower than 2019's revenue of 9.01 billion euros....
Share DSM trading with a premium in chemical sector
The Dutch stock DSM is traded with one the highest CAPE-ratios of the chemical companies. Currently the share is now traded at 425 times the past 10 year's average EPS (CAPE / Shiller PE). With this the stock trades way higher than the average US stock of the...
2020 best year, 2008 worst year for DSM
DSM-investors have very good for long times. Even without dividend payments the stock is one of the outperformers from as well chemical sector as the Dutch exchange. The received dividends are a cherry on the cake for investors. The matrix above shows DSM's...
Analysts count on sales decrease DSM
Over the current book year the total revenue will be 8,92 billion euros (consensus estimates). This is slightly lower than 2019's revenue of 9,01 billion euros. Historical revenues and results DSM plus estimates 2020 DSM Delft building © DSM The analysts...
Annual reports DSM-Firmenich
| 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
Profile DSM-Firmenich
No Records Found
Results DSM-Firmenich
| Resultat |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Intäkter |
|
|
|
|
|
| Kostnader |
|
|
|
|
|
| Vinst |
|
|
|
|
|
| Vinstmarginal |
|
|
|
|
|
| Avkastning på investering |
|
|
|
|
|
Balance DSM-Firmenich
| Balance |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Equity |
|
|
|
|
|
| Debt |
|
|
|
|
|
| Total assets |
|
|
|
|
|
| Solvency |
|
|
|
|
|
| Cash |
|
|
|
|
|
| Cashflow |
|
|
|
|
|
| Employees |
|
|
|
|
|
| Revenue per employee |
|
|
|
|
|
| Cashflow / Debt |
|
|
|
|
|
Details DSM-Firmenich
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
0.0
|
0.0
|
0.0
|
0.0
|
94.38
|
| Eps |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Price/earnings-ratio |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Book value |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Market to book |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Cashflow per stock |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Stocks |
0
|
0
|
0
|
0
|
|
| Market Cap |
0.00
|
0.00
|
0.00
|
0.00
|
|
Dividend DSM-Firmenich
Price info DSM-Firmenich
|
Date
|
Price
|
|---|---|
|
11 Aug 2026
|
94.38
|
|
07 Aug 2026
|
93.70
|
|
06 Aug 2026
|
93.20
|
|
28 Jul 2026
|
81.84
|
|
14 Jul 2026
|
83.82
|
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x |
©2026 ValueSpectrum. All Rights Reserved
Developed and maintained by 